(NASDAQ: FEMY) Femasys's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Instruments & Supplies industry's average forecast earnings growth rate of 28.44%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.43%.
Femasys's earnings in 2026 is -$12,402,402.On average, 5 Wall Street analysts forecast FEMY's earnings for 2026 to be -$20,019,510, with the lowest FEMY earnings forecast at -$20,714,003, and the highest FEMY earnings forecast at -$19,023,064. On average, 5 Wall Street analysts forecast FEMY's earnings for 2027 to be -$16,939,586, with the lowest FEMY earnings forecast at -$18,346,689, and the highest FEMY earnings forecast at -$15,218,451.
In 2028, FEMY is forecast to generate -$14,167,654 in earnings, with the lowest earnings forecast at -$17,163,031 and the highest earnings forecast at -$10,779,736.